The heart pump devices market size has grown rapidly in recent years. It will grow from $4.48 billion in 2025 to $5.32 billion in 2026 at a compound annual growth rate (CAGR) of 19%. The growth in the historic period can be attributed to rising incidence of heart failure, expansion of cardiac surgery programs, advancements in mechanical pump design, increasing transplant wait times, growing use of extracorporeal support systems.
The heart pump devices market size is expected to see rapid growth in the next few years. It will grow to $10.37 billion in 2030 at a compound annual growth rate (CAGR) of 18.1%. The growth in the forecast period can be attributed to increasing demand for long-term circulatory support, rising adoption of destination therapy devices, expansion of minimally invasive cardiac procedures, growing integration of smart monitoring technologies, increasing investments in advanced cardiac care. Major trends in the forecast period include increasing use of advanced ventricular assist devices, rising adoption of temporary mechanical circulatory support, growing focus on miniaturized implantable pumps, expansion of bridge-to-transplant therapies, enhanced monitoring of hemodynamic performance.
The rising prevalence of cardiovascular disorders is anticipated to drive the growth of the heart pump devices market. Cardiovascular disorders encompass conditions affecting the heart and blood vessels. As the incidence of cardiovascular diseases rises, there will be a greater need for advanced diagnostics and treatments, including heart pump devices. These devices are essential for pumping blood from the lower left chamber of the heart, especially during high-risk protected percutaneous coronary interventions, thereby increasing market demand. For example, in March 2024, data from the Office for Health Improvement and Disparities, a UK-based government body, revealed that in 2023, over 1,862,500 individuals (3%) in England had a GP diagnosis of coronary heart disease (CHD). Notably, the proportion of individuals diagnosed with CHD has declined since the financial year ending in 2010. Thus, the increasing prevalence of cardiovascular disorders is fueling the growth of the heart pump devices market.
Major companies operating in the heart pump devices market are developing extracorporeal membrane oxygenation (ECMO) systems to provide advanced life support for patients with severe heart and lung conditions. Extracorporeal membrane oxygenation (ECMO) systems refer to advanced life support machines used to provide prolonged cardiac and respiratory support for patients whose heart and lungs are unable to function properly. For instance, in September 2024, Medtronic plc, an Ireland-based medical device company, launched VitalFlow system, an innovative extracorporeal membrane oxygenation (ECMO) solution designed to provide circulatory support for patients with severe heart or lung failure. The VitalFlow system functions as a heart pump by using a pump and oxygenator to take over the work of the heart and lungs. This is crucial for patients experiencing life-threatening conditions, allowing their organs to rest and heal.
In May 2023, BioForum Inc., a United States-based healthcare technology company, entered into a partnership with Abiomed Inc. to strengthen cardiovascular care solutions. Through this collaboration, BioForum Inc. aims to deliver streamlined and high-quality clinical trial data management and advanced analytics services to Abiomed, thereby improving operational efficiency, accelerating regulatory submission timelines, and supporting the generation of robust real-world evidence. Abiomed Inc. is a United States-based healthcare technology company specializing in the development and manufacture of percutaneous and surgical heart pump systems designed to enhance patient outcomes in heart failure and other circulatory disorders.
Major companies operating in the heart pump devices market are Abbott Laboratories, Medtronic plc, Getinge AB, Terumo Corporation, LivaNova plc, SynCardia Systems Inc, CARMAT SA, Jarvik Heart Inc, BiVACOR Inc, CorWave SA, Fresenius Kabi AG, Asahi Kasei Medical Co Ltd, Nipro Corporation, Eurosets Srl, CardioBridge GmbH, Hemovent GmbH, Evaheart Inc, Calon Cardio-Technology Ltd, Lepu Medical Technology Co Ltd, NewHeart Technologies Inc.
North America was the largest region in the heart pump devices market share in 2025. The regions covered in the heart pump devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the heart pump devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the heart pump devices market by increasing costs of imported medical-grade metals, electronic controllers, sensors, and precision components used in implantable and extracorporeal pump systems. North America and Europe are most affected due to reliance on imported high-complexity components, while Asia-Pacific faces higher manufacturing costs for export-oriented devices. These tariffs are increasing device prices and limiting accessibility in some healthcare systems. However, they are also encouraging localized manufacturing, regional component sourcing, and innovation in cost-efficient heart pump technologies.
The heart pump devices market research report is one of a series of new reports that provides heart pump devices market statistics, including heart pump devices industry global market size, regional shares, competitors with a heart pump devices market share, detailed heart pump devices market segments, market trends and opportunities, and any further data you may need to thrive in the heart pump devices industry. This heart pump devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A heart pump device is a mechanical support device designed to assist in pumping blood from the heart chambers to the rest of the body, temporarily aiding the heart's pumping action.
Heart pump devices come in two main types including implantable heart pump devices and extracorporeal heart pump devices. Implantable heart pump devices are mechanical pumps surgically implanted in the chest to assist a weakened heart in pumping blood. These devices serve various therapeutic purposes, including bridge-to-transplant (BTT), bridge-to-candidacy (BTC), destination therapy (DT), and others. Heart pump devices find applications in diverse healthcare settings, including hospitals, ambulatory surgical centers, specialty clinics, and more.
The heart pump devices market consists of sales of pacemakers, biventricular devices, cardioverter defibrillators, and mechanical assist devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The heart pump devices market size is expected to see rapid growth in the next few years. It will grow to $10.37 billion in 2030 at a compound annual growth rate (CAGR) of 18.1%. The growth in the forecast period can be attributed to increasing demand for long-term circulatory support, rising adoption of destination therapy devices, expansion of minimally invasive cardiac procedures, growing integration of smart monitoring technologies, increasing investments in advanced cardiac care. Major trends in the forecast period include increasing use of advanced ventricular assist devices, rising adoption of temporary mechanical circulatory support, growing focus on miniaturized implantable pumps, expansion of bridge-to-transplant therapies, enhanced monitoring of hemodynamic performance.
The rising prevalence of cardiovascular disorders is anticipated to drive the growth of the heart pump devices market. Cardiovascular disorders encompass conditions affecting the heart and blood vessels. As the incidence of cardiovascular diseases rises, there will be a greater need for advanced diagnostics and treatments, including heart pump devices. These devices are essential for pumping blood from the lower left chamber of the heart, especially during high-risk protected percutaneous coronary interventions, thereby increasing market demand. For example, in March 2024, data from the Office for Health Improvement and Disparities, a UK-based government body, revealed that in 2023, over 1,862,500 individuals (3%) in England had a GP diagnosis of coronary heart disease (CHD). Notably, the proportion of individuals diagnosed with CHD has declined since the financial year ending in 2010. Thus, the increasing prevalence of cardiovascular disorders is fueling the growth of the heart pump devices market.
Major companies operating in the heart pump devices market are developing extracorporeal membrane oxygenation (ECMO) systems to provide advanced life support for patients with severe heart and lung conditions. Extracorporeal membrane oxygenation (ECMO) systems refer to advanced life support machines used to provide prolonged cardiac and respiratory support for patients whose heart and lungs are unable to function properly. For instance, in September 2024, Medtronic plc, an Ireland-based medical device company, launched VitalFlow system, an innovative extracorporeal membrane oxygenation (ECMO) solution designed to provide circulatory support for patients with severe heart or lung failure. The VitalFlow system functions as a heart pump by using a pump and oxygenator to take over the work of the heart and lungs. This is crucial for patients experiencing life-threatening conditions, allowing their organs to rest and heal.
In May 2023, BioForum Inc., a United States-based healthcare technology company, entered into a partnership with Abiomed Inc. to strengthen cardiovascular care solutions. Through this collaboration, BioForum Inc. aims to deliver streamlined and high-quality clinical trial data management and advanced analytics services to Abiomed, thereby improving operational efficiency, accelerating regulatory submission timelines, and supporting the generation of robust real-world evidence. Abiomed Inc. is a United States-based healthcare technology company specializing in the development and manufacture of percutaneous and surgical heart pump systems designed to enhance patient outcomes in heart failure and other circulatory disorders.
Major companies operating in the heart pump devices market are Abbott Laboratories, Medtronic plc, Getinge AB, Terumo Corporation, LivaNova plc, SynCardia Systems Inc, CARMAT SA, Jarvik Heart Inc, BiVACOR Inc, CorWave SA, Fresenius Kabi AG, Asahi Kasei Medical Co Ltd, Nipro Corporation, Eurosets Srl, CardioBridge GmbH, Hemovent GmbH, Evaheart Inc, Calon Cardio-Technology Ltd, Lepu Medical Technology Co Ltd, NewHeart Technologies Inc.
North America was the largest region in the heart pump devices market share in 2025. The regions covered in the heart pump devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the heart pump devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the heart pump devices market by increasing costs of imported medical-grade metals, electronic controllers, sensors, and precision components used in implantable and extracorporeal pump systems. North America and Europe are most affected due to reliance on imported high-complexity components, while Asia-Pacific faces higher manufacturing costs for export-oriented devices. These tariffs are increasing device prices and limiting accessibility in some healthcare systems. However, they are also encouraging localized manufacturing, regional component sourcing, and innovation in cost-efficient heart pump technologies.
The heart pump devices market research report is one of a series of new reports that provides heart pump devices market statistics, including heart pump devices industry global market size, regional shares, competitors with a heart pump devices market share, detailed heart pump devices market segments, market trends and opportunities, and any further data you may need to thrive in the heart pump devices industry. This heart pump devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A heart pump device is a mechanical support device designed to assist in pumping blood from the heart chambers to the rest of the body, temporarily aiding the heart's pumping action.
Heart pump devices come in two main types including implantable heart pump devices and extracorporeal heart pump devices. Implantable heart pump devices are mechanical pumps surgically implanted in the chest to assist a weakened heart in pumping blood. These devices serve various therapeutic purposes, including bridge-to-transplant (BTT), bridge-to-candidacy (BTC), destination therapy (DT), and others. Heart pump devices find applications in diverse healthcare settings, including hospitals, ambulatory surgical centers, specialty clinics, and more.
The heart pump devices market consists of sales of pacemakers, biventricular devices, cardioverter defibrillators, and mechanical assist devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Heart Pump Devices Market Characteristics
3. Heart Pump Devices Market Supply Chain Analysis
4. Global Heart Pump Devices Market Trends and Strategies
5. Heart Pump Devices Market Analysis of End Use Industries
7. Global Heart Pump Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Heart Pump Devices Total Addressable Market (TAM) Analysis for the Market
9. Heart Pump Devices Market Segmentation
10. Heart Pump Devices Market Regional and Country Analysis
11. Asia-Pacific Heart Pump Devices Market
12. China Heart Pump Devices Market
13. India Heart Pump Devices Market
14. Japan Heart Pump Devices Market
15. Australia Heart Pump Devices Market
16. Indonesia Heart Pump Devices Market
17. South Korea Heart Pump Devices Market
18. Taiwan Heart Pump Devices Market
19. South East Asia Heart Pump Devices Market
20. Western Europe Heart Pump Devices Market
21. UK Heart Pump Devices Market
22. Germany Heart Pump Devices Market
23. France Heart Pump Devices Market
24. Italy Heart Pump Devices Market
25. Spain Heart Pump Devices Market
26. Eastern Europe Heart Pump Devices Market
27. Russia Heart Pump Devices Market
28. North America Heart Pump Devices Market
29. USA Heart Pump Devices Market
30. Canada Heart Pump Devices Market
31. South America Heart Pump Devices Market
32. Brazil Heart Pump Devices Market
33. Middle East Heart Pump Devices Market
34. Africa Heart Pump Devices Market
36. Heart Pump Devices Market Competitive Landscape and Company Profiles
37. Heart Pump Devices Market Other Major and Innovative Companies
40. Heart Pump Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Heart Pump Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses heart pump devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for heart pump devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The heart pump devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Implantable Heart Pump Devices; Extracorporeal Heart Pump Devices2) By Therapy: Bridge-To-Transplant (BTT); Bridge-To-Candidacy (BTC); Destination Therapy (DT); Other Therapies
3) By End-user: Hospitals; Cardiac Specialty Hospitals / Heart Centers; Transplant Centers; Other End-Users
Subsegments:
1) By Implantable Heart Pump Devices: Left Ventricular Assist Devices (LVADs); Right Ventricular Assist Devices (RVADs); Biventricular Assist Devices (BiVADs); Total Artificial Hearts (TAHs)2) By Extracorporeal Heart Pump Devices: Intra-Aortic Balloon Pumps (IABPs); Ventricular Assist Devices (Temporary): Centrifugal Blood Pumps
Companies Mentioned: Abbott Laboratories; Medtronic plc; Getinge AB; Terumo Corporation; LivaNova plc; SynCardia Systems Inc; CARMAT SA; Jarvik Heart Inc; BiVACOR Inc; CorWave SA; Fresenius Kabi AG; Asahi Kasei Medical Co Ltd; Nipro Corporation; Eurosets Srl; CardioBridge GmbH; Hemovent GmbH; Evaheart Inc; Calon Cardio-Technology Ltd; Lepu Medical Technology Co Ltd; NewHeart Technologies Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Heart Pump Devices market report include:- Abbott Laboratories
- Medtronic plc
- Getinge AB
- Terumo Corporation
- LivaNova plc
- SynCardia Systems Inc
- CARMAT SA
- Jarvik Heart Inc
- BiVACOR Inc
- CorWave SA
- Fresenius Kabi AG
- Asahi Kasei Medical Co Ltd
- Nipro Corporation
- Eurosets Srl
- CardioBridge GmbH
- Hemovent GmbH
- Evaheart Inc
- Calon Cardio-Technology Ltd
- Lepu Medical Technology Co Ltd
- NewHeart Technologies Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 5.32 Billion |
| Forecasted Market Value ( USD | $ 10.37 Billion |
| Compound Annual Growth Rate | 18.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
